Your browser doesn't support javascript.
loading
Function and mechanism of bispecific antibodies targeting SARS-CoV-2.
Li, Zhaohui; Zhang, Zengyuan; Rosen, Steven T; Feng, Mingye.
Afiliação
  • Li Z; Department of Immuno-Oncology, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Zhang Z; Department of Molecular Microbiology & Immunology, University of Southern California, CA, USA.
  • Rosen ST; Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Feng M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.
Cell Insight ; 3(2): 100150, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38374826
ABSTRACT
As the dynamic evolution of SARS-CoV-2 led to reduced efficacy in monoclonal neutralizing antibodies and emergence of immune escape, the role of bispecific antibodies becomes crucial in bolstering antiviral activity and suppressing immune evasion. This review extensively assesses a spectrum of representative bispecific antibodies targeting SARS-CoV-2, delving into their characteristics, design formats, mechanisms of action, and associated advantages and limitations. The analysis encompasses factors influencing the selection of parental antibodies and strategies for incorporating added benefits in bispecific antibody design. Furthermore, how different classes of parental antibodies contribute to augmenting the broad-spectrum neutralization capability within bispecific antibodies is discussed. In summary, this review presents analyses and discussions aimed at offering valuable insights for shaping future strategies in bispecific antibody design to effectively confront the challenges posed by SARS-CoV-2 and propel advancements in antiviral therapeutic development.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article